Bozh Nalbanski, A Nalbanski
Abstract
The authors discuss the treatment with Azatril for Chlamydia trachomatis infection in patients with tubar sterility. The study includes 85 women, treated for three months. The authors achieved 57.6% negativation of the results that gives a reason to propose the use of Azatril (Balkanpharma) in the treatment of Chlamydial infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The authors discuss the treatment with Azatril for Chlamydia trachomatis infection in patients with tubar sterility. The study includes 85 women, treated for three months. The authors achieved 57.6% negativation of the results that gives a reason to propose the use of Azatril (Balkanpharma) in the treatment of Chlamydial infection.
Key concepts: Chlamydia trachomatis, Chlamydia, Sterility, Chlamydial infection, Medicine, Chlamydiales, Gynecology, Chlamydiaceae